Ambulatory Care Pharmacy

We are recruiting for two Ambulatory Care residents for the 2024-25 year.

Recruitment will occur in-person at ASHP Midyear in Anaheim, California through the PPS platform. We will also be represented at ASHP Midyear Showcase which will occur on Tuesday, December 5th from 8-11 AM (Booth 5244). Please stop by to connect with our residents and RPD!

We will also be at the ACCP x SNPhA virtual showcase on October 24th, 6-7 PM EST.

Unable to attend Midyear or interested in learning more before signing up for a PPS interview in December? Feel free to contact Emily Ashjian ([email protected]) with questions or interest

Rotation Experiences are tailored according to resident interests in conjunction with the residency program director.

Required Rotations (Longitudinal rotations unless otherwise noted)

• Orientation (July)
• Research/Writing (December)
• Independent Patient Centered Medical Home (PCMH)
• Primary Care – PCMH Clinic (Internal Medicine and Family Medicine options; 2 longitudinal rotations)
• Anticoagulation
• Clinical Administration
• Medication Optimization
• Psychiatry
• Transitions of Care Clinic

Elective Rotations (3-4 months; 1/2 day per week)

• Chronic Kidney Disease 
• Cystic Fibrosis
• Hematology/oncology
• Hypertension Clinic
• Oral chemotherapy
• Outpatient infectious diseases stewardship
• Palliative Care
• Pharmacogenomics
• Solid organ transplant
• Specialty pharmacy
• Transitions of care (Geriatrics, Heart Failure options)

• Research project (longitudinal)
• Writing project (longitudinal)
• ACPE-Accredited 1-hour CE Presentation
• Teaching at College of Pharmacy
• Professional and/or institutional committee involvement
• Michigan Medicine Residency Committee involvement
• Attendance at pharmacy meeting (poster presentation)
• Attendance at specialty meeting (not required, but highly encouraged)
• Topic discussions (monthly)
• Journal Club (every other month)
• Student Run Free Clinic (3-4 sessions)

• Teaching certificate program (optional)

Residents will staff in the outpatient Taubman pharmacy approximately every 3^rd weekend, including 1 minor holiday and one major holiday block. Residents receive all minor and major holiday blocks off that they are not scheduled to staff. 

The resident will participate in the development and completion of a mentored longitudinal residency research project. Experience in protocol writing, IRB submission, data collection and analysis, manuscript preparation, and publication will be provided.

Opportunities for development of writing and presentation skills are also available through completion of a writing project suitable for publication, a major pharmacotherapy continuing education presentation on a topic of the resident’s choosing, and presentation opportunities at local, regional, and national meetings.

The resident has the potential to produce at least two manuscripts suitable for peer-reviewed publication by the completion of the residency. There may be additional opportunities depending on resident interest.

Four major oral presentations:

• Research protocol
• Writing project (CE lecture)
• Research project results at Great Lakes residency conference
• Research project results to pharmacy department

A multitude of teaching opportunities are available to the resident, who will receive a faculty appointment as an Adjunct Clinical Instructor at the University of Michigan College of Pharmacy. Resident teaching opportunities include, but are not limited to, the following:

• Teaching in our Pharmacy Practice Skills III Course, which focuses on management of chronic disease states in the ambulatory setting
• Precepting second year Introductory Pharmacy Practice Experience (IPPE) students and fourth-year Advanced Pharmacy Practice (APPE) students on clinical rotations
• Facilitating small group discussions (topic discussions, journal clubs, and case presentations) for APPE students
• Didactic and Team-Based Learning teaching paradigms
• Participating in a teaching series and teaching certificate program
• Providing interdisciplinary presentations and in-services
• Teaching in courses for other health sciences disciplines (Medicine, Nursing, etc.)
• Precepting extracurricular activities in the community for our College of Pharmacy students

Xu J, Ashjian EJ. Treatment of hypertriglyceridemia: A review of therapies in the pipeline. J Pharm Pract 2023;36(3):650-661.

 Xu-Stettner J, Thompson AN, Fitzgerald LJ, et al. Comparison of transplant pharmacist treatment decisions between telehealth and clinic visits. Prog Transplant 2023;33(2):156-161.

Elder MJ, Ashjian EJ. Pharmacotherapy for Type 2 Diabetes Mellitus: What’s up and coming in the Glucagon-Like Peptide-1 (GLP-1) pipeline? J Pharm Pract 2023;36(2):418-428.

Dualeh SHA, McMurry K, Herman AE, Maryan S, Pacurar LA, Waits SA, Tishcer S. Evaluation of an opioid restrictive pain management initiative in adult kidney transplant recipients. Clin Transplant 2021;35(7):e14313.

Johengen EK, Ward KM, Coe AB, Pasternak AL. Assessing the knowledge, perceptions, and practices of primary care clinicians toward pharmacogenetics. J Am Coll Clin Pharm. 2020 [epub ahead of print].

Cho KH, Ashjian EJ, Smith MA, Pai AB. Approaches to medication management in patients with kidney failure opting for conservative management. Nephrol Nurs J. 2020;47(4):319-71.

Aldrich SA, Ashjian EJ. Use of GLP-1 receptor agonists in patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease. Nurse Pract 2019;44(3):20-28.

Farhat NM, Vordenberg SE, Marshall VD, Suh TT, Remington TL. Evaluation of interdisciplinary geriatric transitions of care on readmission rates. Am J Manag Care. 2019;25(7):e219-e223.

Farhat NM, Farris KB, Patel MR, Cornish L, Choe HM. Comprehensive medication reviews: Optimal delivery setting and recommendations for quality assessment. J Am Pharm Assoc 2019;59(5):642-645.

Fennelly JE, Coe AB, Kippes KA, Remington TL, Choe HM. Evaluation of clinical pharmacist services in a transitions of care program provided to patients at highest risk for readmission. J Pharm Pract. 2020;33(3):314-320.

Lindell, VA, Stencel DL, Ives RC, Ward KM, Fluent T, Choe HM, Bostwick JR. A pilot evaluating clinical pharmacy services in an ambulatory psychiatry setting. Psychopharmacol Bull. 2018;48(2):18-28.

Ashjian EJ, Kurtz B, Renner E, Yeshe R, Barnes GD. Evaluation of a Pharmacist-Led Direct Oral Anticoagulant Service. Am J Health-Syst Pharm 2017;74(7):483-89.

Ashjian EJ, Tingen JM. SGLT2 inhibitors: Expanding oral treatment options for type 2 diabetes mellitus. Nurse Pract 2017;42(4): 8-15.

Funk KA, Hudson S, TIngen JM. Use of clinical pharmacists to perform depression screening. Qual Prim Care. 2014;22(5):249-50.

Stranges PM, Marshall VD, Walker PC, Hall KE, Griffith DK, Remington T. A multidisciplinary intervention for reducing readmissions among older adults in a patient-centered medical home. Am J Manag Care. 2015;21(2):106-13.

Stranges PM, Tingen JM. End of the road: Diabetes care when insulin may not be an option. Clin Diabetes. 2014;32(2):87-9.

• Emily Ashjian, PharmD, BCPS, BCACP, CDCES
• Jennifer Baldridge, PharmD, BCACP
• Anisa Bici, PharmD
• Nick Dillman, PharmD
• Heidi Diez, PharmD, BCACP
• Mary Jo Elder, PharmD, BCACP
• Nada Farhat, PharmD, BCPS, BCACP
• Jessica Fennelly, PharmD, BCACP, BC-ADM
• Lianne Granata, PharmD
• Nghi Ha, PharmD, MPH, BCPS, CACP
• Marcy Holler, PharmD
• Kellie Kippes, PharmD, BCPS, BCACP
• Lan Le, PharmD, BCACP
• Valerie Lindell, PharmD, BCACP
• Amy Pasternak, PharmD, BCPS
• Hanna Phan, PharmD, FCCP, FPPA
• Elizabeth Renner, PharmD, BCPS, BCACP, CACP
• Nicole Rockey, PharmD, BCACP
• Mike Smith, PharmD, BCPS 
• Denise Sutter-Long, PharmD, BCPS
• Amy Thompson, PharmD, BCACP
• Kristen Ward, PharmD, BCPP
• Trisha Wells, PharmD

Emily Ashjian, PharmD, BCPS, BCACP, CDCES
Program Director & Ambulatory Care Clinical Pharmacist Specialist
Michigan Medicine

Clinical Associate Professor
University of Michigan College of Pharmacy
428 Church Street
Ann Arbor, MI
Email: [email protected]